Agency veteran Kate Paxton appointed to lead operation, bringing nearly 30 years of global and US biopharma experience.
Fairfield, CT, US, OCTOBER 12, 2021 — Global healthcare communications consultancy 90TEN, part of Envision Pharma Group, today announced its expansion to the US market and appointment of Kate Paxton as its US Head.
Paxton will oversee projects with a number of current 90TEN and Envision Pharma Group clients, grow her US team of healthcare communications specialists, leverage the existing rich resources within the organization for US client needs, and showcase the agency and its unique culture and approach.
“We are thrilled to have such an experienced and passionate professional like Kate join the growing 90TEN team,” said David Thompson, Chief Executive Officer, Envision Pharma Group. “Kate’s long history of building strategic and creative programs for healthcare clients of every size and scope – in addition to her deep understanding of how agencies grow and thrive – makes her ideally suited to lead 90TEN through this next, exciting phase.”
Paxton has almost 30 years of experience in agency communications and healthcare, ranging from corporate communications, product comms, and advocacy relations – to celebrity campaigns and issues management. Prior to 90TEN, Paxton spent a year and a half at JPA Health, where she designed and led campaigns for several biotech companies focused on oncology and rare diseases, and almost 23 years at Ketchum, where she held multiple leadership positions, including Managing Director of London Health for over 2 years and Practice Director of Washington, D.C. Health for over 7 years.
Campaigns that Paxton led have won multiple industry awards, including three Silver Anvils from the Public Relations Society of America and one Healthcare Campaign of the Year from PR Week.
“I have been an admirer of 90TEN for many years and always respected how bold, creative, and effective their campaigns are,” Paxton said. “So, when the opportunity came to lead the US launch and rollout, maximize the incredible talent and resources that already exist, and work with the award-winning London team – all of whom are passionate about changing lives for the better – I jumped at the chance.”
Based in London, 90TEN is one of the leading healthcare communications consultancies in Europe and works with half of the top 20 pharma companies in the world serving clients across Europe and North America. In 2020, it was named Communications Consultancy of the Year at both the Communiqué Awards and Sabre EMEA Awards. That same year, it became part of Envision Pharma Group – a global provider of evidence-based communication services and industry-leading technology solutions.
Thompson added, “The US PR marketplace is highly competitive, but given the pairing of Envision’s footprint and deep scientific capabilities with 90TEN’s award-winning, behavioral science approach, we are confident that 90TEN US represents an exciting new offering for the American market.”
— Ends –
90TEN, part of the Envision Pharma Group, is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and communications. 90TEN provides PR, medical communications, and patient advocacy services that use behavioral science methodologies to maximize brand and health outcomes. To find out more, visit www.90TENHealth.com.
About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a global, innovative technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions (iEnvision) that have applicability across many areas of medical affairs and related functional responsibility. Envision Pharma Group provides services and technology solutions to more than 90 companies, including all of the top 20 pharmaceutical companies.
Envision has 20 offices: six in the United Kingdom – Bishop’s Stortford, Glasgow, Horsham, London, Wilmslow, and Alderley Edge; one in Serbia – Subotica; one in Hungary – Szeged; one in Coimbra, Portugal, nine in the United States – Fairfield and Glastonbury, CT, Philadelphia and Wyomissing, PA, Warren, NJ, Boston and Melrose, MA, Powell, OH, Pasadena, CA; and two in the Asia-Pacific region – Tokyo and Sydney. The company employs 1100+ team members, including over 250 highly qualified and experienced in-house medical writers, and 200 technology solutions team members who provide software development and customer support. To find out more, visit www.envisionpharmagroup.com.
For further information:
Global Head of Marketing
Envision Pharma Group
Tel: +44 (0)7557 083549